Graham Number Checker

Date Checked2026-02-19 22:17:46
Graham Number(PB)50.24 vs (PE)52.90
Over / Under Value Percentage144.30% vs 139.02%
Dividend Yield2.59%
Dividend Date2025-12-30
SymbolGILD
AssetTypeCommon Stock
NameGilead Sciences Inc
DescriptionGilead Sciences, Inc. is a premier biopharmaceutical company headquartered in Foster City, California, recognized for its innovative research and development in antiviral therapies, particularly for HIV and hepatitis. Its breakthrough products, including Harvoni and Sovaldi, have revolutionized the treatment landscape for chronic hepatitis C, reflecting the company’s commitment to addressing urgent healthcare challenges. With a robust and expanding therapeutic pipeline, Gilead continues to focus on unmet medical needs, positioning itself as a pivotal force in improving global health outcomes and advancing patient care.
CIK882095
ExchangeNASDAQ
CurrencyUSD
CountryUSA
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - GENERAL
Address333 LAKESIDE DRIVE, FOSTER CITY, CA, UNITED STATES, 94404
OfficialSitehttps://www.gilead.com
FiscalYearEndDecember
LatestQuarter2025-09-30
MarketCapitalization154294338000
EBITDA14136001000
PERatio19.22
PEGRatio0.227
BookValue17.34
DividendPerShare3.14
EPS6.47
RevenuePerShareTTM23.35
ProfitMargin0.279
OperatingMarginTTM0.452
ReturnOnAssetsTTM0.126
ReturnOnEquityTTM0.407
RevenueTTM29087001000
GrossProfitTTM22896001000
DilutedEPSTTM6.47
QuarterlyEarningsGrowthYOY1.43
QuarterlyRevenueGrowthYOY0.03
AnalystTargetPrice133.84
AnalystRatingStrongBuy5
AnalystRatingBuy16
AnalystRatingHold8
AnalystRatingSell0
AnalystRatingStrongSell0
TrailingPE19.22
ForwardPE14.14
PriceToSalesRatioTTM5.3
PriceToBookRatio7.16
EVToRevenue5.91
EVToEBITDA12.57
Beta0.349
52WeekHigh127.86
52WeekLow86.16
50DayMovingAverage122.74
200DayMovingAverage113.89
SharesOutstanding1240680000
SharesFloat1238037000
PercentInsiders0.097
PercentInstitutions91.712
ExDividendDate2025-12-15
naga1
etoro1
dateChecked2026-02-19 22:17:46
fresh1